Core Insights - Lucid Motors unexpectedly won the auction for Nikola's assets, including its Arizona factory, for approximately $30 million in cash and non-cash considerations [1][3][5] - The acquisition aligns with Lucid's production schedule for the Gravity model and aims to enhance its manufacturing, warehousing, testing, and R&D capabilities [3][5] Company Actions - Lucid plans to extend job offers to around 300 former Nikola employees across various roles, including manufacturing, engineering, software, assembly, vehicle testing, and warehousing [3] - The company confirmed that it will not take over Nikola's hydrogen truck business or its customers as part of the deal [3][5] Market Context - The auction outcome surprised the market, as Lucid focuses on passenger electric vehicles and has not engaged in hydrogen-powered vehicles, which are central to Nikola's business [5] - Nikola's founder, Trevor Milton, who was previously convicted of fraud, was barred from inspecting the factory and assets prior to the auction [5]

According to Needham, Lucid Diagnostics Inc. LUCD is likely to receive approval for EsoGuard testing-related Medicare reimbursement, which would boost testing volumes.The Lucid Diagnostics Analyst: Analyst Mike Matson maintained a Buy rating and price target of $3.The Lucid Diagnostics Thesis: The company completed over 25,000 cumulative EsoGuard tests (DNA tests) through the fourth quarter of 2024 and filed for Medicare reimbursement, which is expected to come through in the first half of 2025, Matson said ...

It's been an incredibly turbulent week for stocks in the electric vehicle (EV) sector and for markets in general. As of early Friday morning, the Nasdaq Composite index was 5.4% higher for the week mainly thanks to Wednesday's historic rally.Shares of EV maker Lucid Group (LCID -1.19%) were doing even better, surging by 10.5%, according to data provided by S&P Global Market Intelligence. Those gains have come partly because of struggles at EV leader Tesla. Investors should be aware of something that could c ...

NEW YORK, April 11, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced underwritten public offering of 14,375,000 shares of its common stock, including 1,875,000 shares issued pursuant to the exercise of the underwriters' option to purchase additional shares, at a public offering price of $1.20 per share.T ...

Core Points - Lucid Group, Inc. has reached an agreement to acquire select facilities and assets from Nikola Corporation, pending approval from the U.S. Bankruptcy Court [1][4] - The acquisition includes Nikola's former manufacturing and headquarters facilities in Arizona, adding over 884,000 square feet to Lucid's operations [3] - Lucid plans to offer employment to more than 300 former Nikola employees, enhancing its workforce with experienced personnel in EV technology [2][5] Company Expansion - The acquisition aligns with Lucid's strategy to expand its manufacturing, warehousing, testing, and development capabilities in Arizona [5] - The facilities acquired include state-of-the-art manufacturing and warehousing buildings, as well as advanced testing equipment [3] - This move supports Lucid's production ramp of the Lucid Gravity and upcoming midsize platform vehicles [5] Community Impact - The acquisition is expected to benefit the local Arizona community by providing continued employment opportunities for skilled workers [5] - Arizona Governor Katie Hobbs highlighted the positive impact on the state's growing EV and battery manufacturing industry [5] - State Senator T.J. Shope emphasized the importance of the investment in helping those affected by job loss regain employment [5]

Core Insights - Lucid Motors has unexpectedly won the bankruptcy auction for Nikola's Arizona factory and other assets, committing approximately $30 million in cash and non-cash considerations [1][2] - The acquisition includes Nikola's lease on its Phoenix headquarters, along with certain machinery, equipment, and inventory [1] - Lucid plans to offer jobs to around 300 former Nikola employees as part of the deal [2] Group 1: Acquisition Details - Lucid Motors' bid was surprising as Nikola had been attempting to sell its entire business since filing for bankruptcy protection in February [2] - The acquisition is strategic for Lucid, which already operates a factory in Casa Grande, Arizona, allowing for increased warehousing space and testing equipment [3] - The bankruptcy judge has allowed objections to the sale until April 11, with a hearing scheduled for the same day [4] Group 2: Background Context - Nikola's founder, Trevor Milton, who was previously convicted of fraud, attempted to bid on the assets but was blocked from inspecting them prior to the auction [3] - Lucid's focus has primarily been on passenger electric vehicles, contrasting with Nikola's involvement in hydrogen-powered electric vehicles [2]

Lucid (NASDAQ: LCID) stock’s performance in the last 30 days has been nothing short of stellar as the electric vehicle (EV) maker soared 20.57% to $2.52 within the time frame.LCID stock 30-day price chart. Source: FinboldThe rally is made even more remarkable because it took place at a time when most of its peers – as well as equity from other sectors – have been under severe pressure from the now-postponed Liberation Day tariffs.In the last 24 hours, Lucid shares benefited significantly from a +$0.23 (9.91 ...

The automotive industry is highly loyal, and one of the biggest challenges is "conquesting" consumers, which is simply one brand taking a customer from another. Since Tesla (TSLA 22.25%) vehicles hit the roads, the company has thoroughly dominated the U.S. market in sales volumes, but a recent backlash against the once unflappable brand may have sent consumers fleeing to a competitor you might not expect: Lucid (LCID 9.91%). Lucid's interim CEO made some very intriguing comments recently, and investors shou ...

Core Viewpoint - Lucid Diagnostics Inc. has announced a public offering of 12,500,000 shares at a price of $1.20 per share, aiming to raise approximately $15 million for working capital and general corporate purposes [1][2]. Company Overview - Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company and a subsidiary of PAVmed Inc. The company focuses on patients with gastroesophageal reflux disease (GERD), who are at risk of developing esophageal precancer and cancer [6]. Offering Details - The offering includes a 45-day option for underwriters to purchase an additional 1,875,000 shares at the public offering price [1]. - The gross proceeds from the offering are expected to be around $15 million, excluding any proceeds from the underwriters' option [2]. - The offering is expected to close on or about April 11, 2025, subject to customary closing conditions [2]. Underwriters - Canaccord Genuity LLC is acting as the sole bookrunner for the offering, while Maxim Group LLC is serving as co-manager [3]. Regulatory Information - The offering is made pursuant to a shelf registration statement declared effective by the Securities and Exchange Commission on December 6, 2022 [4]. - A prospectus supplement will be filed with the SEC, and the securities may only be offered by means of a written prospectus [4].

Core Viewpoint - Lucid Group, Inc. has successfully closed a $1.1 billion convertible senior notes offering due in 2030, which is expected to enhance its growth prospects and strengthen its partnership with the Public Investment Fund (PIF) [2][3]. Group 1: Offering Details - The offering includes an aggregate principal amount of $1.1 billion in convertible senior notes, with an additional $100 million option exercised by initial purchasers [2]. - The effective conversion price of the notes is set at $4.80 per share, representing a 100% premium over the last reported sale price of $2.40 per share on April 2, 2025 [3]. - The net proceeds from the offering are approximately $1,082.2 million after deducting discounts, commissions, and estimated expenses [4]. Group 2: Use of Proceeds - Approximately $935.6 million of the net proceeds will be used to repurchase about $1,052.5 million of existing 1.25% convertible senior notes due in 2026 [4]. - About $118.3 million of the net proceeds is allocated to cover the costs of capped call transactions [4]. - The remaining proceeds will be utilized for general corporate purposes [4]. Group 3: Strategic Implications - The partnership with the PIF is highlighted as a key strategic differentiator for Lucid, aiding in its pursuit of a sustainable future [3]. - The company has the flexibility to settle conversions in cash, shares, or a combination, which may help manage potential dilution or cash obligations [5].